Creating a Scientific Superpower

Wednesday 28 June
08:30	Registration and breakfast
09:20	Chair’s opening remarks Max Bryan, head of science & technology, Bidwells Tim Burke, deputy editor, EG
09:30	Opening keynote: Perspectives of a Supercluster Sir Jonathan Symonds CBE, life sciences champion and chair, GSK
09:50	Accelerating innovation as a key driver of our economic future Future technologies – the need for long-term strategic plans and investment The role of universities – how do we continue to support spin-outs? How do we make the UK more attractive for R&D and the best scientific talent Baroness Nicola Blackwood, chair, Genomics England Sir Peter Knight, senior research investigator, Imperial College London, National Quantum Strategy Steve Rees OBE, vice president of discovery biology, AstraZeneca Lord David Willetts, president, Resolution Foundation, chair, UK Space Agency Chair: Dr Barbara Ghinelli, director, Innovation Clusters and Harwell Campus, UKRI STFC
10:35	Keynote: Cementing the UK as a Scientific Superpower The Rt Hon Chloe Smith MP, secretary of state for science, innovation and technology
10:55	Networking and refreshment break
11:20	The power of clusters: Unleashing scientific convergence Sue Foxley, research director, Bidwells
11:30	Creating a world-class supercluster through the convergence of science and technology How can we enable the convergence of science and technology within the Arc? Nurturing vibrant clusters to encourage collaboration and knowledge-sharing How do we make the UK more attractive for R&D and the best scientific talent Katherine Morgan, head of high growth & entrepreneurs, Barclays Sharon Parker-Lines, deputy managing director and operations director, Astroscale UK Kristin-Anne Rutter, executive director, Cambridge Biodmedical Campus Isobel Stephen, executive director – strategy, performance and engagement, UKRI Chair: Sarah Haywood, managing director, Advanced Oxford
12:15	Evolution of real estate for a new era of science and technology Defining the next generation of world-leading science, manufacturing and laboratory buildings What is needed to build Green Labs Building science and technology real estate that benefits the community Emma Cariaga, joint head of Canada Water & head of residential, British Land Jenny Gardner, director of development, ARC Artem Korolev, founder & chief executive Mission Street Orestis Tzortzoglou, vice-president of development, BioMed Realty Chair: Richard Todd, head of Oxford, Bidwells
13:00	Lunch break
13:45	Revaluation of science and technology: The investor outlook Emerging opportunities and investment outlook in science and technology Funding science and technology in the UK vs other markets How do we fast-track the scaling of UK innovation? Dr Glenn Crocker, executive director, Pioneer Group Hitesh Thakrar, partner, Syncona Investment Management Rebecca Todd, investment director, Longwall Venture Partners Chair: Tim Burke, deputy editor, EG
14:30	In conversation with: East West rail as a catalyst for scientific growth Neil Sachdev MBE, chair, East West Railway Company Tim Burke, deputy editor, EG
14:50	Networking and refreshment break
15:20	Keynote: Unleashing Innovation for a Net Zero Future The Rt Hon Grant Shapps MP, secretary of state for energy security and net zero
15:40	Unleashing the Oxford-Cambridge Corridor as an engine for growth How does the OxCam Arc maximise return on investment? Unlocking the Arc’s potential through infrastructure The Arc’s global brand on the international stage Richard Hutchins, managing director, Oxford to Cambridge Partnership Neelam Patel, chief executive, Med City Sir John Peace, chair, Midlands Engine Dr Andy Williams, chair, Oxford-Cambridge Supercluster board Chair: Professor Andy Neely OBE, senior pro-vice-chancellor for enterprise and business, University of Cambridge
16:25	Breaking boundaries: Global science and tech giants investing in the UK Karen Frieze, head of healthcare, Life Sciences & Bioeconomy, Investment Services Team, Department for Business and Trade Greg Pada, vice-president, head of engineering business, AVEVA Sheelpa Patel, chief marketing officer, Oxa Professor Wolf Reik, director, Altos Labs, Cambridge Institute of Science Professor Matthew Snape, vice-president, paediatric and maternal vaccine clinical development, Moderna Chair: Tim Burke, deputy editor, EG
17:15	Chair’s closing remarks